Context Therapeutics (FRA:6K9) Other Long Term Assets : €-0.00 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Context Therapeutics Other Long Term Assets?

Context Therapeutics's other long-term assets for the quarter that ended in Mar. 2024 was €-0.00 Mil.

Context Therapeutics's quarterly other long-term assets increased from Sep. 2023 (€-0.00 Mil) to Dec. 2023 (€0.00 Mil) but then stayed the same from Dec. 2023 (€0.00 Mil) to Mar. 2024 (€-0.00 Mil).

Context Therapeutics's annual other long-term assets declined from Dec. 2021 (€0.05 Mil) to Dec. 2022 (€0.03 Mil) and declined from Dec. 2022 (€0.03 Mil) to Dec. 2023 (€0.00 Mil).

Context Therapeutics Other Long Term Assets Historical Data

The historical data trend for Context Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Context Therapeutics Other Long Term Assets Chart

Context Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

0.03

0.14

0.05

0.03

Context Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial													0.02	0.02	-	-	-

Context Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Context Therapeutics (FRA:6K9) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Context Therapeutics Inc (FRA:6K9) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

CNTX:USA 6K9:Germany

Address

2001 Market Street, Suite 3915, Unit No. 15, Philadelphia, PA, USA, 19103

Website

https://www.contexttherapeutics.com

Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer.

Context Therapeutics (FRA:6K9) Headlines

No Headlines